PharmaShots Weekly Snapshots (January 03 - 07, 2021)
Published: Jan 07, 2022 | Tags: ObsEva, Linzagolix, P-III, EDELWEISS 3 Trial, Endometriosis-Associated Pain
Published: Jan 07, 2022 | Tags: AstraZeneca, Neurimmune, NI006, ATTR-CM
Published: Jan 07, 2022 | Tags: Exscientia, Sanofi, Cancer, Immunology
Published: Jan 07, 2022 | Tags: Lilly, Entos, Nucleic Acid Therapies, Neurologic
Stryker Signs a Definitive Agreement to Acquire Vocera Communications for ~$3.09B
Published: Jan 07, 2022 | Tags: Stryker, Vocera Communications, ~$3.09B
Published: Jan 07, 2022 | Tags: Amgen, Generate Biomedicines, Protein Therapeutics
Junshi Entered into a Collaboration with DotBio to Develop Cancer Therapies
Published: Jan 06, 2022 | Tags: Junshi, DotBio, Cancer, DotBody modules
Published: Jan 06, 2022 | Tags: Exelixis, P-III, CONTACT-03 Trial, Cabometyx, cabozantinib, atezolizumab, Metastatic RCC
Published: Jan 06, 2022 | Tags: BeiGene, Tislelizumab, NMPA, Approval, Non-Small Cell Lung Cancer
Published: Jan 06, 2022 | Tags: Jazz, Xywav, P-III, Study, Idiopathic Hypersomnia, Lancet Neurology
Published: Jan 06, 2022 | Tags: NiKang, AVEO, NKT2152, Fotivda, tivozanib, Advanced Clear Cell Renal Cell Carcinoma
Published: Jan 06, 2022 | Tags: Intellia, Kyverna, KYV-201, Autoimmune Diseases
Published: Jan 05, 2022 | Tags: Amryt, Mycapssa, P-III, MPOWERED Trial, Acromegaly, Lancet, Diabetes, Endocrinology
Amylyx Reports Submission of MAA to EMA for AMX0035 to Treat ALS
Published: Jan 05, 2022 | Tags: Amylyx, MAA, EMA, AMX0035, ALS
Published: Jan 05, 2022 | Tags: AbbVie, Telisotuzumab Vedotin, Teliso-V, US, FDA, Breakthrough Therapy Designation, Non-Small Cell Lung Cancer
Published: Jan 05, 2022 | Tags: Biogen, Ionis, BIIB115, ION306, SMA
Published: Jan 05, 2022 | Tags: AVEO, Merck KGaA, Ficlatuzumab, Erbitux, cetuximab, Recurrent, Metastatic, HNSCC
Genmab Signs a License Agreement with Synaffix for ADC Technology to Treat Cancer
Published: Jan 05, 2022 | Tags: Genmab, Synaffix, ADC, Technology, Cancer
Published: Jan 04, 2022 | Tags: Hansa Biopharma, AskBio, Imlifidase, Pompe Disease
Published: Jan 04, 2022 | Tags: Allarity, Oncoheroes Biosciences, Dovitinib, Stenoparib, Pediatric Cancer
Published: Jan 04, 2022 | Tags: UNION, P-IIb, IASOS Study, Orismilast, Psoriasis
Published: Jan 04, 2022 | Tags: Santhera, Sperogenix, Vamorolone, Rare Diseases, Greater China, DMD, US, EU
Published: Jan 04, 2022 | Tags: Asieris, Neoadjuvant Therapy, MIBC, Patients, APL-1202, BeiGene, tislelizumab
Pfizer and BioṆTech’ s Booster Receive the US FDA’s EUA for Adolescents
Published: Jan 04, 2022 | Tags: Pfizer, BioṆTech, Booster, COVID-19, US, FDA, EUA, Adolescents
Published: Jan 03, 2022 | Tags: Ovid Therapeutics, AstraZeneca, OV329, Pregabalin, Tuberous sclerosis, Soticlestat, Dravet, Lennox Gastaut Syndromes
Published: Jan 03, 2022 | Tags: Bionomics, BNC210, Social Anxiety Disorder, US FDA, US IRB, PTSD
Cantargia Plans to Evaluate Nadunolimab Against Metastatic Pancreatic Cancer
Published: Jan 03, 2022 | Tags: Cantargia, Nadunolimab, Metastatic Pancreatic Cancer, US, FDA,
Novavax Submits Final Data to Seek the US FDA’s EUA for its COVID-19 Vaccine
Published: Jan 03, 2022 | Tags: Novavax, US, FDA, EUA, COVID-19, Vaccine, NVX-CoV2373, Matrix-M
Published: Jan 03, 2022 | Tags: Kintor Pharma, P-III, Study, KX-826, pyrilutamide, Androgenic Alopecia, China
Related Post: PharmaShots Weekly Snapshots (December 27- 31, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com